dc.date.accessioned2021-06-08T15:46:15Z
dc.date.available2021-06-08T15:46:15Z
dc.date.created2021-06-08T15:46:15Z
dc.date.issued2021
dc.identifierhttps://hdl.handle.net/20.500.12866/9518
dc.identifierhttps://doi.org/10.3389/fimmu.2021.641082
dc.description.abstractBACKGROUND: Whole blood mycobacterial growth assays (WBMGA) quantify mycobacterial growth in fresh blood samples and may have potential for assessing tuberculosis vaccines and identifying individuals at risk of tuberculosis. We evaluated the evidence for the underlying assumption that in vitro WBMGA results can predict in vivo tuberculosis susceptibility. METHODS: A systematic search was done for studies assessing associations between WBMGA results and tuberculosis susceptibility. Meta-analyses were performed for eligible studies by calculating population-weighted averages. RESULTS: No studies directly assessed whether WBMGA results predicted tuberculosis susceptibility. 15 studies assessed associations between WBMGA results and proven correlates of tuberculosis susceptibility, which we divided in two categories. Firstly, WBMGA associations with factors believed to reduce tuberculosis susceptibility were statistically significant in all eight studies of: BCG vaccination; vitamin D supplementation; altitude; and HIV-negativity/therapy. Secondly, WBMGA associations with probable correlates of tuberculosis susceptibility were statistically significant in three studies of tuberculosis disease, in a parasitism study and in two of the five studies of latent tuberculosis infection. Meta-analyses for associations between WBMGA results and BCG vaccination, tuberculosis infection, tuberculosis disease and HIV infection revealed consistent effects. There was considerable methodological heterogeneity. CONCLUSIONS: The study results generally showed significant associations between WBMGA results and correlates of tuberculosis susceptibility. However, no study directly assessed whether WBMGA results predicted actual susceptibility to tuberculosis infection or disease. We recommend optimization and standardization of WBMGA methodology and prospective studies to determine whether WBMGA predict susceptibility to tuberculosis disease
dc.languageeng
dc.publisherFrontiers Media
dc.relationFrontiers in Immunology
dc.relation1664-3224
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectrisk
dc.subjecttuberculosis
dc.subjectMGIA
dc.subjectmycobacterial growth assay
dc.subjectmycobacterial growth inhibition assay
dc.subjectsusceptibility
dc.titleWhole Blood Mycobacterial Growth Assays for Assessing Human Tuberculosis Susceptibility: A Systematic Review and Meta-Analysis
dc.typeinfo:eu-repo/semantics/review


Este ítem pertenece a la siguiente institución